Table 2.
Comparison of general information in the intervention group.
| Variables | L1 (n = 50) | L2 (n = 50) | L3 (n = 50) | M1 (n = 50) | M2 (n = 50) | M3 (n = 50) | P |
|---|---|---|---|---|---|---|---|
| Genders | |||||||
| Male | 25 | 25 | 25 | 23 | 26 | 24 | .995 |
| Female | 25 | 25 | 25 | 27 | 24 | 26 | |
| Age, yr | 66.54 ± 9.64 | 65.74 ± 9.65 | 69.30 ± 11.54 | 63.92 ± 9.22 | 65.60 ± 10.62 | 65.48 ± 8.37 | .152 |
| Hypertension | 34 | 37 | 46 | 34 | 39 | 46 | .003 |
| BMI (kg/m2) | 24.31 ± 3.13 | 25.18 ± 3.49 | 24.23 ± 2.32 | 24.27 ± 3.22 | 24.28 ± 2.93 | 23.75 ± 2.77 | .311 |
| TG (mmol/L) | 1.17 ± 0.48 | 1.30 ± 0.54 | 1.16 ± 0.45 | 1.30 ± 0.52 | 1.15 ± 0.46 | 1.34 ± 0.56 | .220 |
| TC (mmol/L) | 4.02 ± 1.01 | 4.05 ± 1.03 | 4.39 ± 1.20 | 4.18 ± 1.01 | 4.09 ± 1.18 | 4.17 ± 1.17 | .603 |
| LDL-C (mmol/L) | 2.43 ± 0.80 | 2.48 ± 0.95 | 2.81 ± 1.14 | 2.29 ± 0.76 | 2.58 ± 1.06 | 2.55 ± 1.12 | .293 |
| HDL-C (mmol/L) | 1.11 ± 0.24 | 1.08 ± 0.26 | 1.20 ± 0.32 | 1.12 ± 0.32 | 1.14 ± 0.29 | 1.22 ± 0.29 | .207 |
| FBG (mmol/L) | 5.73 ± 0.50 | 5.80 ± 0.54 | 5.69 ± 0.49 | 5.66 ± 0.48 | 5.67 ± 0.47 | 5.73 ± 0.51 | .745 |
| Currently taking oral medications | |||||||
| Beta-blocker | 26 | 23 | 23 | 25 | 21 | 22 | .869 |
| Propafenone | 13 | 13 | 13 | 14 | 14 | 14 | |
| Moresizine | 11 | 14 | 14 | 11 | 15 | 14 | |
| HAMA | 7.10 ± 1.55 | 8.48 ± 1.17 | 12.02 ± 2.29 | 7.66 ± 1.92 | 8.30 ± 1.19 | 11.88 ± 2.52 | .000 |
BMI = body mass index, FBG = fasting blood glucose, HAMA = Hamilton Anxiety Scale score, HDL-C = high-density lipoprotein, LDL-C = low-density lipoprotein, TC = cholesterol, TG = triglycerides.